FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000508004: Great Britain English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001112010 Great Britain English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001113017 GB English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001114011 Great Britain English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


1327206 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
GB English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
2019-nCoV antigen vaccination Acceptable (foundation metadata concept)
2019-nCoV antigen vaccination not indicated Acceptable (foundation metadata concept)
2019-nCoV antigen vaccine contraindicated Acceptable (foundation metadata concept)
2019-nCoV antigen vaccine declined Acceptable (foundation metadata concept)
2019-nCoV detected Acceptable (foundation metadata concept)
2019-nCoV immunisation Acceptable (foundation metadata concept)
2019-nCoV mRNA immunisation Acceptable (foundation metadata concept)
2019-nCoV mRNA vaccination Acceptable (foundation metadata concept)
2019-nCoV mRNA vaccination not indicated Acceptable (foundation metadata concept)
2019-nCoV mRNA vaccine contraindicated Acceptable (foundation metadata concept)
2019-nCoV mRNA vaccine declined Acceptable (foundation metadata concept)
2019-nCoV non-replicating viral vector immunisation Acceptable (foundation metadata concept)
2019-nCoV non-replicating viral vector vaccination Acceptable (foundation metadata concept)
2019-nCoV non-replicating viral vector vaccine contraindicated Acceptable (foundation metadata concept)
2019-nCoV non-replicating viral vector vaccine declined Acceptable (foundation metadata concept)
2019-nCoV not detected Acceptable (foundation metadata concept)
2019-nCoV recombinant spike protein antigen immunisation Acceptable (foundation metadata concept)
2019-nCoV recombinant spike protein antigen vaccination Acceptable (foundation metadata concept)
2019-nCoV recombinant spike protein antigen vaccine contraindicated Acceptable (foundation metadata concept)
2019-nCoV recombinant spike protein antigen vaccine declined Acceptable (foundation metadata concept)
2019-nCoV vaccination Acceptable (foundation metadata concept)
2019-nCoV vaccination not indicated Acceptable (foundation metadata concept)
2019-nCoV vaccination not indicated Acceptable (foundation metadata concept)
2019-nCoV vaccine contraindicated Acceptable (foundation metadata concept)
2019-nCoV vaccine contraindicated Acceptable (foundation metadata concept)
2019-nCoV vaccine declined Acceptable (foundation metadata concept)
2019-nCoV vaccine declined Acceptable (foundation metadata concept)
2019-nCoV virus-like particle antigen immunisation Acceptable (foundation metadata concept)
2019-nCoV virus-like particle antigen vaccination Acceptable (foundation metadata concept)
2019-nCoV virus-like particle antigen vaccine contraindicated Acceptable (foundation metadata concept)
2019-nCoV virus-like particle antigen vaccine declined Acceptable (foundation metadata concept)
201m-Bi Acceptable (foundation metadata concept)
201m-Pb Acceptable (foundation metadata concept)
202-Bi Acceptable (foundation metadata concept)
202-Pb Acceptable (foundation metadata concept)
202-Tl Acceptable (foundation metadata concept)
202m-Pb Acceptable (foundation metadata concept)
203-Bi Acceptable (foundation metadata concept)
203-Hg Acceptable (foundation metadata concept)
203-Pb Acceptable (foundation metadata concept)
203.6 Preferred (foundation metadata concept)
203.6 (qualifier value) Preferred (foundation metadata concept)
204-Bi Acceptable (foundation metadata concept)
204-Tl Acceptable (foundation metadata concept)
204m-Pb Acceptable (foundation metadata concept)
205-Bi Acceptable (foundation metadata concept)
205-Pb Acceptable (foundation metadata concept)
206-Bi Acceptable (foundation metadata concept)
206-Tl Acceptable (foundation metadata concept)
207-Bi Acceptable (foundation metadata concept)
207-Tl Acceptable (foundation metadata concept)
207m-Pb Acceptable (foundation metadata concept)
208-Bi Acceptable (foundation metadata concept)
208-Tl Acceptable (foundation metadata concept)
208.333 Preferred (foundation metadata concept)
208.333 (qualifier value) Preferred (foundation metadata concept)
209-Bi Acceptable (foundation metadata concept)
209-Pb Acceptable (foundation metadata concept)
209-Tl Acceptable (foundation metadata concept)
20G Preferred (foundation metadata concept)
20G (qualifier value) Preferred (foundation metadata concept)
20M post incubation Acceptable (foundation metadata concept)
20alpha-hydroxysteroid dehydrogenase Acceptable (foundation metadata concept)
20p partial trisomy syndrome Preferred (foundation metadata concept)
20p partial trisomy syndrome (disorder) Preferred (foundation metadata concept)
20p subtelomeric deletion syndrome Acceptable (foundation metadata concept)
20p12.2 deletion syndrome Preferred (foundation metadata concept)
20p12.2 deletion syndrome (disorder) Preferred (foundation metadata concept)
20p12.3 microdeletion syndrome Preferred (foundation metadata concept)
20p12.3 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
20p12.3 microdeletion syndrome is a recently described syndrome characterised by Wolff-Parkinson-White syndrome, variable developmental delay and facial dysmorphism. Preferred (foundation metadata concept)
20p13 microdeletion syndrome Preferred (foundation metadata concept)
20p13 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
20p13 microdeletion syndrome is a rare chromosomal anomaly characterised by developmental delay, mild to moderate intellectual disability, epilepsy, and unspecific dysmorphic signs. High palate, delayed permanent tooth eruption, hypoplastic fingernails, clinodactyly and short fingers have also been reported. Preferred (foundation metadata concept)
20q partial trisomy Preferred (foundation metadata concept)
20q partial trisomy (disorder) Preferred (foundation metadata concept)
20q11.2 microdeletion syndrome Preferred (foundation metadata concept)
20q11.2 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
20q11.2 microduplication syndrome Preferred (foundation metadata concept)
20q11.2 microduplication syndrome (disorder) Preferred (foundation metadata concept)
20q11.2 microduplication syndrome is a rare chromosomal anomaly syndrome, due to partial duplication of the long arm of chromosome 20, characterised by psychomotor and developmental delay, moderate intellectual disability, metopic ridging/trigonocephaly, short hands and/or feet and distinctive facial features (epicanthus, hypoplastic supraorbital ridges, horizontal/downslanting palpebral fissures, small nose with depressed nasal bridge and anteverted nostrils, prominent cheeks, retrognathia and small, thick ears). Growth delay and cryptorchidism are often associated features. Preferred (foundation metadata concept)
20q13.33 microdeletion syndrome Preferred (foundation metadata concept)
20q13.33 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
21 Preferred (foundation metadata concept)
21 (AJCC) Acceptable (foundation metadata concept)
21 (UICC) Acceptable (foundation metadata concept)
21 (qualifier value) Preferred (foundation metadata concept)
21 DAY FLEA & TICK DIP Preferred (foundation metadata concept)
21 DAY FLEA & TICK DIP (product) Preferred (foundation metadata concept)
21 gene breast recurrence score Preferred (foundation metadata concept)
21 gene breast recurrence score (observable entity) Preferred (foundation metadata concept)
21-Hydroxylase antibody assay Acceptable (foundation metadata concept)
21-Ne Acceptable (foundation metadata concept)
21-deoxycorticosterone Preferred (foundation metadata concept)
21-deoxycorticosterone (substance) Preferred (foundation metadata concept)
21-deoxycortisol Preferred (foundation metadata concept)
21-deoxycortisol (substance) Preferred (foundation metadata concept)
21-hydroxylase Acceptable (foundation metadata concept)
21-hydroxylase antibody Acceptable (foundation metadata concept)
21-hydroxylase deficiency Acceptable (foundation metadata concept)
21-hydroxylase deficiency Preferred (foundation metadata concept)

Start Previous Page 90 of 13273 Next End


Reference Sets

Reference set descriptor

Back to Start